Immunovia announces updated financial calendar
LUND (SWEDEN) – Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company focused on early detection of pancreatic cancer, updates its financial calendar for 2023. The Q2 interim report will be published on Wednesday, August 30, 2023. The previously communicated date was Wednesday, August 23, 2023. For more information, please contact: Karin Almqvist Liwendahl, CFOkarin.almqvist.liwendahl@immunovia.com+46 70 911 56 08 About ImmunoviaImmunovia is a diagnostic company with the vision to revolutionize blood-based diagnostics and increase survival rates for